There is currently no official indication or established evidence base for using GLP-1 medications specifically to treat vasomotor symptoms associated with menopause, and they should not be used off-label for this purpose
They tried indomethacin a few years ago
1, 2 GLP-1 drugs build on this idea, but they act on multiple pathways at once, making them a potentially more powerful approach
Healing is more than just making tissue grow, its also doing it in the right place, the right amount, at the right time
Polarized anti-inflammatory mesenchymal stem cells increase hippocampal neurogenesis and improve cognitive function in aged mice
Genetic Predisposition and Your GLP-1 Response: Who Benefits From Which Approach Key genetic variants in GIPR and FTO, and MC4R influence how your body processes hunger signals and metabolic regulation